423 related articles for article (PubMed ID: 12224984)
1. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
De Korte J; Mombers FM; Sprangers MA; Bos JD
Arch Dermatol; 2002 Sep; 138(9):1221-7; discussion 1227. PubMed ID: 12224984
[TBL] [Abstract][Full Text] [Related]
2. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.
Bronsard V; Paul C; Prey S; Puzenat E; Gourraud PA; Aractingi S; Aubin F; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Richard-Lallemand MA; Ortonne JP
J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():17-22. PubMed ID: 20443996
[TBL] [Abstract][Full Text] [Related]
3. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of patient-reported outcome instruments of nonmelanoma skin cancer in the dermatologic population.
Lee EH; Klassen AF; Nehal KS; Cano SJ; Waters J; Pusic AL
J Am Acad Dermatol; 2013 Aug; 69(2):e59-67. PubMed ID: 23102770
[TBL] [Abstract][Full Text] [Related]
5. Critical review of generic and dermatology-specific health-related quality of life instruments.
Both H; Essink-Bot ML; Busschbach J; Nijsten T
J Invest Dermatol; 2007 Dec; 127(12):2726-39. PubMed ID: 17989733
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
7. Quality of life assessments in dermatology.
Finlay AY
Semin Cutan Med Surg; 1998 Dec; 17(4):291-6. PubMed ID: 9859917
[TBL] [Abstract][Full Text] [Related]
8. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.
Augustin M; Wenninger K; Amon U; Schroth MJ; Küster W; Chren M; Kupfer J; Gieler U
Dermatology; 2004; 209(1):14-20. PubMed ID: 15237262
[TBL] [Abstract][Full Text] [Related]
9. A method to select an instrument for measurement of HR-QOL for cross-cultural adaptation applied to dermatology.
de Tiedra AG; Mercadal J; Badía X; Mascaró JM; Lozano R
Pharmacoeconomics; 1998 Oct; 14(4):405-22. PubMed ID: 10344908
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.
Finlay AY; Salek MS; Haney J;
Dermatology; 2003; 206(4):307-15. PubMed ID: 12771471
[TBL] [Abstract][Full Text] [Related]
11. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
12. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
13. The Norwegian version of the dermatology life quality index: a study of validity and reliability in psoriatics.
Mørk C; Wahl A; Moum T
Acta Derm Venereol; 2002; 82(5):347-51. PubMed ID: 12430733
[TBL] [Abstract][Full Text] [Related]
14. [Creation and cross-cultural adaptation of the Ukrainian versions of SKINDEX-29, SKINDEX-16 questionnaires, Psoriasis Disability Index and further validation of the Ukrainian version of the Dermatology Life Quality Index].
Chernyshov PV
Lik Sprava; 2009; (1-2):95-8. PubMed ID: 19953996
[TBL] [Abstract][Full Text] [Related]
15. A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.
Ali FM; Cueva AC; Vyas J; Atwan AA; Salek MS; Finlay AY; Piguet V
Br J Dermatol; 2017 Mar; 176(3):577-593. PubMed ID: 27273146
[TBL] [Abstract][Full Text] [Related]
16. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
17. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
18. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials.
McKenna SP; Cook SA; Whalley D; Doward LC; Richards HL; Griffiths CE; Van Assche D
Br J Dermatol; 2003 Aug; 149(2):323-31. PubMed ID: 12932239
[TBL] [Abstract][Full Text] [Related]
19. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
Ellis CN; Mordin MM; Adler EY;
Am J Clin Dermatol; 2003; 4(2):131-9. PubMed ID: 12553852
[TBL] [Abstract][Full Text] [Related]
20. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.
Nijsten T; Meads DM; de Korte J; Sampogna F; Gelfand JM; Ongenae K; Evers AW; Augustin M
J Invest Dermatol; 2007 Oct; 127(10):2315-22. PubMed ID: 17495953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
